Literature DB >> 29991328

CYP3A5 and ABCB1 polymorphisms in living donors do not impact clinical outcome after kidney transplantation.

Lin Yang1, Brenda Cm de Winter2, Ron Hn van Schaik3, Rui-Xiang Xie1, Yi Li4, Louise M Andrews2, Nauras Shuker2, Soma Bahmany2, Birgit Koch2, Teun van Gelder2,5, Dennis A Hesselink5.   

Abstract

AIM: To investigate the association between donor CYP3A5 and ABCB1 polymorphisms and tacrolimus (Tac)-induced nephrotoxicity and renal function in kidney transplant recipients.
METHODS: The CYP3A5 6986A>G and ABCB1 3435C>T polymorphisms were determined in 237 recipients and donors.
RESULTS: There was no significant association between Tac-related nephrotoxicity and donor CYP3A5 and ABCB1 genotype. The donor ABCB1 3435C>T polymorphism was associated with estimated glomerular filtration rate on day 7 and month 1. The combined donor-recipient ABCB1 genotype (3435C>T polymorphism) was significantly related with estimated glomerular filtration rate on day 3 and 7 in univariate analysis. However, these differences were no longer statistically significant in multivariate analysis.
CONCLUSION: A genetic analysis of ABCB1 and CYP3A5 of kidney transplant donors is not helpful to improve renal transplant outcomes.

Entities:  

Keywords:  ABCB1; CYP3A5; kidney transplantation; living donor; nephrotoxicity; renal function; single-nucleotide polymorphism; tacrolimus

Mesh:

Substances:

Year:  2018        PMID: 29991328     DOI: 10.2217/pgs-2018-0066

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  2 in total

Review 1.  Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation.

Authors:  Camille Tron; Florian Lemaitre; Céline Verstuyft; Antoine Petitcollin; Marie-Clémence Verdier; Eric Bellissant
Journal:  Clin Pharmacokinet       Date:  2019-05       Impact factor: 6.447

2.  Donor CYP3A5 Expression Decreases Renal Transplantation Outcomes in White Renal Transplant Recipients.

Authors:  Karola Warzyszyńska; Michał Zawistowski; Edyta Karpeta; Agnieszka Jałbrzykowska; Maciej Kosieradzki
Journal:  Ann Transplant       Date:  2022-07-26       Impact factor: 1.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.